Katherine Rifiotis Slivensky

Associate

Chicago + 1.312.269.4124

Connect:

Share

Katherine Slivensky focuses her practice on advising public companies and private equity funds on mergers and acquisitions and related corporate governance matters. Her practice includes domestic and cross-border transactions, as well as corporate restructurings. She also represents institutional investors in connection with primary and secondary investments.

Prior to attending law school, Katherine worked as a policy analyst at a Department of Energy nuclear physics laboratory and later joined the compliance team of a Fortune 500 financial services firm, where she focused on regulatory strategy and organizational risk management.

Experience

  • Riverside acquires OnvivJones Day advised The Riverside Company in the acquisition and financing by healthcare portfolio company Decera Clinical of Onviv, Inc., a healthcare and medical intelligence platform.
  • Adams Street Partners acquires portfolio of private equity fund interestsJones Day represented Adams Street Partners in the acquisition of a portfolio of private equity fund interests from a global investment management firm with an aggregate net asset value in excess of $400 million.
  • Nutrien completes $1 billion Senior Notes offeringJones Day represented Nutrien Ltd. in connection with a public offering of US$1 billion of Senior Notes, consisting of (i) US$500 million aggregate principal amount of 4.850% Senior Notes due 2031 and (ii) US$500 million aggregate principal amount of 5.350% Senior Notes due 2036.
  • BioMarin acquires Amicus Therapeutics for $4.8 billionJones Day advised BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) in its $4.8 billion acquisition of Amicus Therapeutics (Nasdaq: FOLD).
  • WESCO Distribution completes $1.5 billion Senior Notes offeringJones Day represented WESCO International, Inc., a leading provider of business-to-business distribution, logistics services and supply chain solutions, in connection with its $1.5 billion Rule 144A and Regulation S offering of Senior Notes, consisting of $650 million of 5.250% Senior Notes due 2031 and $850 million of 5.500% Senior Notes due 2034 by direct subsidiary of WESCO International, Inc.
  • U.S. Marine Corps veteran granted permanent and total disability ratingJones Day represented a U.S. Marine Corps veteran before the Department of Veterans Affairs through the Firm's Vetlex program.
    • View All

    April 2026 Podcast

    JONES DAY TALKS®: Perspectives and Pathways Conference Delivers Career Guidance to Top Law School Talent

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.